XML 60 R44.htm IDEA: XBRL DOCUMENT v3.22.4
Organization (Narrative) (Details) - USD ($)
1 Months Ended 12 Months Ended
Apr. 30, 2019
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Noncontrolling Interest [Abstract]            
Net loss at subsidiary allocated to noncontrolling interests   $ 79,798 $ 95,212      
Charitable contribution of shares (in shares)           50,000
Committed cash contributions       $ 25,000 $ 50,000  
Cash contributions   $ 25,000        
Cumberland Emerging Technologies, Inc (CET)            
Noncontrolling Interest [Abstract]            
Noncontrolling interest, ownership percentage by parent   85.00%        
HongKong WinHealth Pharma Group Co. Limited            
Noncontrolling Interest [Abstract]            
Investment in CET $ 1,000,000          
Contribution of cash 300,000          
Conversion of intercompany loans payable 700,000          
Gloria Pharmaceuticals            
Noncontrolling Interest [Abstract]            
Exchange for consideration, amount $ 800,000          
Cumberland Emerging Technologies, Inc (CET) | Harbin Gloria Pharmaceuticals Co            
Noncontrolling Interest [Abstract]            
Exercise of options and related tax benefit   $ 1,000,000